Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has informd that it enclosed the schedule of Earnings Call to be held on February 10, 2026 at 8:30 am (IST) on the Unaudited Financial Results of the Company for the third quarter and nine months period ended December 31, 2025.
The above information is a part of company’s filings submitted to BSE.